Pomegra
CVS Health (CVS) plans to separate its drugstore chain from Aetna and Caremark into two public companies by early 2028, and shares rose after hours.
- CVS Health reportedly plans two listed companies by the first half of 2028, undoing most of its $78 billion Aetna deal.
- Shares closed at $91.41 on Tuesday, up 3.3%, and rose about $0.50 more after hours.
- The retail arm is about a third of CVS's roughly $417 billion in revenue.
Lead
CVS Health (NYSE: CVS) plans to split into two publicly traded companies by the first half of 2028. One will hold its roughly 9,000 drugstores and the other will hold Aetna and Caremark. The plan was reported on Tuesday, November 3, ahead of the company's third-quarter results. The stock rose in after-hours trading, adding about $0.50 to its $91.41 close, which had already gained 3.3% in the regular session. The company could announce the plan alongside earnings on Wednesday, though the structure and timeline are described as subject to change.
What Is the Proposed Structure of the CVS Split?
The plan creates one retail-focused company and one benefits-focused company, and current shareholders would receive shares in both.
The retail company would run the drugstore network, mail-order pharmacy, MinuteClinic and the Health100 digital tool. The second company would keep the Aetna insurance arm, the Caremark pharmacy benefit manager, Oak Street Health, Signify Health and the specialty pharmacy business. Chief executive David Joyner is expected to lead the insurance-focused company.
The retail division generates about a third of CVS's annual revenue of roughly $417 billion. The split would reverse the integrated model CVS built with its $78 billion purchase of Aetna in 2018.
Why Is CVS Breaking Up Now?
CVS is breaking up now because vertical integration in healthcare has become a political and legislative target.
Lawmakers are scrutinizing companies that own insurers, pharmacy benefit managers and pharmacies at once, over concerns about conflicts of interest and drug pricing. Arkansas and Tennessee have enacted laws that bar pharmacy benefit managers from owning pharmacies. The same pressure extends to peers such as UnitedHealth Group (UNH), which operates a similar insurer, benefit manager and care-delivery model.
Operating pressure adds to the case. Insurers have faced rising medical costs, and drugstore chains have faced weak margins and store closures. Separating the businesses lets each be valued and managed against its own peers rather than as one conglomerate.
How Did the Stock React?
CVS shares rose about 4.5% across Tuesday's regular and extended sessions. The stock closed at $91.41, up $2.90, then traded near $91.91 after hours.
Gains had been building into the earnings release. Shares were up roughly 10.5% for the year before the report. Wall Street expected third-quarter earnings of $1.65 per share on revenue of about $104.7 billion, against $1.60 per share in the same quarter a year earlier. The extended-hours move reflects investor appetite for a breakup that could close the valuation gap between a retail business and a managed-care and benefits business.
What Does the Split Mean for Healthcare Peers?
The split sets a precedent for other integrated healthcare groups facing the same regulatory scrutiny.
Rivals that combine insurance, pharmacy benefit management and retail operations may face pressure to explain their own structures. A CVS separation would also reduce one of the largest examples of common ownership between a benefit manager and a national pharmacy chain. For investors in healthcare equities, the decision reframes the sector's debate from integration synergies to regulatory risk.
What Comes Next for CVS Health?
The next step is the earnings release and any formal confirmation of the plan on Wednesday. Open questions include the legal structure of the separation, the debt each company would carry, the tax treatment of the distribution and the names of the new entities. A target of early 2028 leaves more than a year of preparation, including regulatory filings and shareholder materials.
Outlook
CVS Health is moving to undo its 2018 Aetna combination, splitting a drugstore network of about 9,000 locations from its insurance and benefit management operations. The market has so far rewarded the plan, with the stock up roughly 4.5% over Tuesday's regular and after-hours trading. Execution risk remains, as the structure and timeline are not final. The first formal details are expected with third-quarter results.
Mentioned tickers: CVS, UNH
